News Industry News FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease July 15, 2019
News Industry News Jubilant DraxImage Inc. Receives CE Mark Certificate for Its Medical Device RUBY Rubidium Elution System™ (RbES) and Proprietary RUBY™ Consumable Accessories June 07, 2019
News Industry News AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device August 08, 2017